Publications by authors named "Julen Rodriguez-Castejon"

Claim this Profile
C
Cationic Green Solid Lipid nanoparticles by the fatty acid coacervation method for gene delivery to the cornea: preliminary studies on cell and isolated tissue models.
Annalisa Bozza, Marina Beraza-Millor, Julen Rodríguez-Castejón, Francisco Andres Soto Arratia, Roberta Cavalli

Eur J Pharm Biopharm· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asialofetuin-Coupled Lipid-Based nanosystems to target the Asialoglycoprotein receptor: Delivering genes to hepatocytes for the treatment of Fabry disease.
Julen Rodríguez-Castejón, Paula Fernández-Muro, Marina Beraza-Millor, María Ángeles Solinís, Alicia Rodríguez-Gascón

Eur J Pharm Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review.
Julen Rodríguez-Castejón, Marina Beraza-Millor, María Ángeles Solinís, Alicia Rodríguez-Gascón, Ana Del Pozo-Rodríguez

Drug Deliv Transl Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review of Genetic Substrate Reduction Therapy in Lysosomal Storage Diseases: Opportunities, Challenges and Delivery Systems.
Marina Beraza-Millor, Julen Rodríguez-Castejón, Ana Del Pozo-Rodríguez, Alicia Rodríguez-Gascón, María Ángeles Solinís

BioDrugs· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Community Pharmacy Interventions on Patients with Medicines Under Additional Monitoring.
Xabier Aizpurua-Arruti, Shalom Charlie I Benrimoj, Estibaliz Goyenechea, Arantxa Isla, Ainhoa Oñatibia-Astibia

Integr Pharm Res Pract· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Golden Lipid Nanoparticles with Small Interference Ribonucleic Acid for Substrate Reduction Therapy in Fabry Disease.
Marina Beraza-Millor, Julen Rodríguez-Castejón, Jonatan Miranda, Ana Del Pozo-Rodríguez, Alicia Rodríguez-Gascón

Pharmaceutics· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA delivery technologies: Toward clinical translation.
Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Marina Beraza-Millor, Alicia Rodríguez-Gascón, Ana Del Pozo-Rodríguez

Int Rev Cell Mol Biol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galactomannan-Decorated Lipidic Nanocarrier for Gene Supplementation Therapy in Fabry Disease.
Julen Rodríguez-Castejón, Itziar Gómez-Aguado, Marina Beraza-Millor, María Ángeles Solinís, Ana Del Pozo-Rodríguez

Nanomaterials (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA-Based Nanomedicinal Products to Address Corneal Inflammation by Interleukin-10 Supplementation.
Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Marina Beraza-Millor, Mónica Vicente-Pascual, Alicia Rodríguez-Gascón

Pharmaceutics· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice.
Julen Rodríguez-Castejón, Ana Alarcia-Lacalle, Itziar Gómez-Aguado, Mónica Vicente-Pascual, María Ángeles Solinís Aspiazu

Pharmaceutics· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleic Acid Delivery by Solid Lipid Nanoparticles Containing Switchable Lipids: Plasmid DNA vs. Messenger RNA.
Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Mónica Vicente-Pascual, Alicia Rodríguez-Gascón, Ana Del Pozo-Rodríguez

Molecules· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical Administration of SLN-Based Gene Therapy for the Treatment of Corneal Inflammation by De Novo IL-10 Production.
Mónica Vicente-Pascual, Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Alicia Rodríguez-Gascón, Elisabetta Muntoni

Pharmaceutics· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene Therapy.
Ana Del Pozo-Rodríguez, Alicia Rodríguez-Gascón, Julen Rodríguez-Castejón, Mónica Vicente-Pascual, Itziar Gómez-Aguado

Adv Biochem Eng Biotechnol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives.
Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Mónica Vicente-Pascual, Alicia Rodríguez-Gascón, María Ángeles Solinís

Nanomaterials (Basel)· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis